Although there is a universal acknowledgement that health inequalities need to be addressed, the question is “How?” Precision’s Jason Shafrin and Meena Venkatachalam explain that simply incentivizing research and development efforts to create new drugs in therapeutic areas that disproportionately impact minorities won’t resolve the problem. Rather, we need to change traditional value assessment frameworks to move towards equity in health outcomes.

Read the full article here!